3Burrell L M,Chan R,Phillips P A,et al.Validation of anechocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat[J].Clin Exp Pharmacol Physiol,1996,23:570.
4Van Bilsen M,Smeets P J,Gilde A J,et al.Metabolic remodeling of the failing heart:the cardiac burn-out syndrome?[J].Cardiovasc Res,2004,61(2):218.
6Ingwall JS,Weiss RG.Is the failing heart energy starved On using chemical energy to support cardiac function [J].Circ Res, 2004,95 (2): 135-145.
7Ferrari R, Merli E, Cicchtelli G, et al.Theraputic effects of L carnitine and propionyl L carnitine on cardiovascular diseases : a review[J].Arm N Y Acad Sei, 2004,1033 (6) : 79-91.
8Regitz V,Shug AL,Fleck E.Defective myocardial carnitine metabo-lism in congestive heart failure secondary to dilated cardiomyopathyand to coronary,hypertensive and valvular heart diseases[J].Am JCardiol,1990,65 :755-760.
9Khazanov VA,Kiseliova AA,Vasiliev KY,et al.Cardioprotectiveeffects of Itimetazidine and a combination of succinic and maolicacids in acute myocardial ischemia[J].Bull Exp Biol med,2008 ,146(2):218-222.
10Belardinelli R,Solenghi M ,Volpe L,et al.Trimetazidine improvesendothelial dysfunction in chronic heart failure ; an antioxidant effect[J].Eur Heart J,2007,28(9):1102-1108.
